Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 7 consecutive quarters of double digit growth. Click here to learn more ›

Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: results from basic research and clinical studies

Scroll to Top